When was Transpact founded?

Transpact was founded in 2013 and raised its 1st funding round 2 years after it was founded.

Where is Transpact located?

Transpact is headquartered in Mumbai, India. It is registered at 204 2ND FLOOR, TIMMY ARCADE, MAKWANA ROAD MAROL, ANDHERI EAST, Mumbai City, MUMBAI, Maharashtra, India, 400059.

Who is the current CEO of Transpact?

Mohammed Aslam Qudratullah Khan of Transpact.

Which legal entities is Transpact associated with?

Transpact is associated with TRANSPACT ENTERPRISES LIMITED and 1 other.

How many employees does Transpact have?

As of Sep 30, 2026, the latest employee count at Transpact is 6.

Is Transpact a funded company?

Transpact is a funded company, having raised a total of $241K across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 14, 2015.

When was the latest funding round of Transpact?

Transpact's latest funding was a $***** Seed round on Aug 31, 2019, with participation from 10 investors. Its primary sector is Neurology. Globally, the Neurology sector has seen $6.27B in funding in 2026 to date.

What is the annual revenue of Transpact?

Annual revenue of Transpact is less than ₹10 Cr as on Mar 31, 2025

Where does Transpact rank among its competitors?

Transpact ranks 12th amongst 115 active competitors, of which 22 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was LIFESCAPES, which secured an undisclosed amount in Oct, 2026.

Who are the top competitors of Transpact?

Transpact's top competitors include Nexstim, Precision Neuroscience and Blackrock Neurotech. Among them, LIFESCAPES secured the most recent funding round in October, 2026.

Transpact - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of a therapeutic device to stimulate the vestibular system. The company's products include a Vestibulator Chair a therapy device for at-home therapy of children suffering from vestibular dysfunction and developmental disorders, and Vestibulator provides stimulations for neuro-developmental and sensory integration therapy. Also, it offers cloud-based therapy and rehabilitation software solutions.

Website: transpact.in
Social
Email ID: *****@transpact.in
Phone Number: +91 **********
Registered Address: 204 2ND FLOOR, TIMMY ARCADE, MAKWANA ROAD MAROL, ANDHERI EAST, Mumbai City, MUMBAI, Maharashtra, India, 400059

Key Metrics

Founded Year

2013

Location

Mumbai, India

Stage

Public

Total Funding

$241K in 4 rounds

Latest Funding Round

Seed, Aug 31, 2019, $*****

Investors

Octaware Technologies & 72 more

Ranked

12^th among 115 active competitors

Annual Revenue

0 - ₹10 Cr as on Mar 31, 2025

Employee Count

6 as on Sep 30, 2026

Similar Companies

Nexstim & 130 more

Exit Details

Public

View Transpact's full profile

Transpact is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
TRANSPACT MEDTECH PRIVATE LIMITED CIN: U86904MH2023PTC403595 , India, Active	May 26, 2023	0 - ₹10 Cr (As on Mar 31, 2025)	-
TRANSPACT ENTERPRISES LIMITED CIN: U66110MH2013PLC243247 , India, Active	May 12, 2013	0 - ₹10 Cr (As on Mar 31, 2025)	-

Transpact got listed on Sep 05, 2019.

Click here to take a look at Transpact's IPO in detail

Transpact has raised a total funding of $241K over 4 rounds. Its first funding round was on Nov 14, 2015. Its latest funding round was a Seed round on Aug 31, 2019 for $*****. 10 investors participated in its latest round. Transpact has 4 institutional investors and 69 angel investors.

Here is the list of recent funding rounds of Transpact:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 31, 2019	2835600	Seed	5722851	5934387	2875684	8153073
Dec 26, 2017	9218730	Seed	6623489	6526092	9188137	6152938
Feb 25, 2016	8370678	Seed	8412795	3649798	Adam Mahmood Thakur & 1 more	SINE

Access funding benchmarks and valuations. Sign up today!

View details of Transpact's funding rounds and investors

The founders of Transpact is Mohammed Aslam Qudratullah Khan.

Here are the details of Transpact's key team members:

Mohammed Aslam Qudratullah Khan: Co-Founder & CEO of Transpact and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address and 1 phone number

Transpact's Board of Directors

Transpact's board has 5 active members. Mohammed Aslam Qudratullah Khan and Anis Choudhery are part of team and Moiz Mohsin Miyajiwala, Soummya Sudhir Bania and Shariq Nisar are independent board members.

Here is the list of Transpact's board of directors:

Name	Type	Representing	Status	Duration
Mohammed Aslam Qudratullah Khan	Team	-	Current	13y 5m
a{lillj	Team	-	Past	7y 7m
enecubo	Team	-	Past	8y 9m
dfrjntv	Independent board member	-	Past	3y 2m
rwwhvo{	Independent board member	-	Past	9y 2m
blneqjo	Independent board member	-	Past	6y 7m

View details of Transpact's Founder profiles and Board Members

Transpact's employee count trend

Transpact has 6 employees as of Sep 26. Here is Transpact's employee count trend over the years:

Uncover Transpact's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Transpact include Nexstim, Precision Neuroscience and Blackrock Neurotech. Here is the list of Top 10 competitors of Transpact, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nexstim 2000, Helsinki (Finland), Public	Provider of noninvasive brain stimulation for rehabilitating stroke patients	$29.7M	Kreos Capital, Lundbeck Foundation & 9 others	69/100
2nd	Precision Neuroscience 2021, New York City (United States), Series D	Developed of brain-computer interface tool for medical treatment and drug development	$433M	PERSHING SQUARE, Ackman Oxman Institute & 18 others	68/100
3rd	Blackrock Neurotech 2008, Salt Lake City (United States), Acquired	Developer of medical devices for neurological therapies	$22.4M	re.Mind Capital, Cavendish Privateers & 12 others	53/100
4th	LIFESCAPES 2018, Minato City (Japan), Series A	Developer of brain-machine interface devices for neurorehabilitation	$3.74M	Beyond Next Ventures, Shionogi & 9 others	51/100
5th	Vielight 1995, Toronto (Canada), Funding Raised	Developer of a PDM device for brain and circulatory stimulation	-	MaRS Discovery District	47/100
6th	Synergia Medical 2013, Mont Saint Guibert (Belgium), Series B	Developer of an active implantable neurostimulator and contact-less patient monitoring system	$14.2M	Newton Biocapital, SFPI & 8 others	44/100
7th	Endonovo Therapeutics 2011, Los Angeles (United States), Public	Bioelectronic devices and therapies for regenerative medicine	-	Kodiak Capital, Azure Capital Partners & 2 others	44/100
8th	Minnetronix Medical 1996, Saint Paul (United States), Acquired	Manufacturer of multiple devices for neurocritical patients	$20M	Altaris, NIH & 1 others	43/100
9th	BIONIK 2010, Toronto (Canada), Public	Provider of assistive and rehabilitation hardware and software solutions	-	Ginger Capital, MBX Capital & 3 others	43/100
10th	g.tec 1999, Schiedlberg (Austria), Funding Raised	Provider of high-performance brain-computer interfaces and neurotechnologies for invasive and non-invasive recordings	-	EIC Fund, Europa	41/100
12th	Transpact 2013, Mumbai (India), Public	Developer of a therapeutic device to stimulate the vestibular system	$241K	SINE, Aryaman & 71 others	40/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Transpact's competitors? Click here to see the top ones

TRANSPACT ENTERPRISES LIMITED, the legal entity associated with Transpact, generated less than ₹10 Cr in revenue for the financial year ending on Mar 31, 2025.

Financial Statement Summary

Metrics	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21
Income Statement
Revenue	5262	9721	7321	1503	4945
Total Sales	9968	8335	2867	4095	2839
Total Expenses	9199	3344	2548	1047	9122
Operating Expenses	2511	1841	2199	6497	1098
Employee Expenses	3524	4620	2455	1657	6731
Operating Income (EBIT)	8737	4967	4281	5764	2327
Interest Expenses	8554	4696	8718	9180	9481
Expenses from other activities	7772	9584	6583	4889	6529
EBITDA	3193	4659	5809	2865	3267
Taxes	2333	9330	5367	1682	2695
Net Profit	6422	8959	9005	5153	8619
Balance Sheet
Assets	1185	6346	1093	9844	9107
Cash Equivalent	5584	7272	5845	9037	6433
Accounts Receivables	7752	2341	6761	4992	6136
Inventory	6009	8584	2008	5882	4608
Liabilities	1285	2698	5266	2752	5554
Total Debt	8671	4734	9545	2847	6057
Accounts Payable	8159	8221	7145	7041	8553
Equities	8972	2769	5734	9218	2094
Cashflow Statement
Cash from Operating activities	5427	1818	4851	8404	7481
Cash from Investing activities	8243	1094	4845	2351	7751
Net cash from Financing activities	8145	6432	1306	4084	6796

Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)

Founders (largest shareholder) own 52.90%, Funds own 1.00%, Enterprises own 13.37% and Angels own 28.52%. The net worth of Transpact's founders is INR 2.66Cr as of Aug 31, 2019. The cap table displayed below is for TRANSPACT ENTERPRISES LIMITED which is the legal entity associated with Transpact.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	52.90%	2.66Cr	5940963	3019507	6918173	1333161
Mohammed Aslam Qudratullah Khan	3278384	6055148	5781010	1354685	2123090	9049678
Fund	1.00%	5.02L	0	0	0	0
SINE	0	0	0	0	0	0
Enterprise	13.37%	67.2L	1202101	8872663	7895044	1074864
Angel	28.52%	1.43Cr	8837991	7944412	4538239	4846150
Sultan Abdul Kader	11	68	34	52	43	26
Adam Mahmood Thakur	0	0	0	0	0	0
Other People	4.21%	21.2L	4083	4034	1392	1083
Total	100.00%	5.03Cr	5797760	1630207	6982676	3938339